Bureau of Communicable Disease
The mission of the Bureau of Communicable Disease (BCD) is to prevent and control designated communicable diseases and illness in Alabama. BCD consists of the following divisions:
- The Centers for Disease Control and Prevention (CDC) laboratory is overwhelmed with chikungunya requests and test results may be delayed. The only private lab in the U.S. performing chikungunya testing is Focus Diagnostics. Focus Diagnostics has accounts with most large reference labs (i.e. Quest, LabCorp, Mayo, ARUP) and many local hospitals. In order to receive more timely results, providers can submit their chikungunya test request to a reference laboratory that has an account with Focus Diagnostics.
- If a healthcare provider suspects a patient to have chikungunya with recent travel history (Southern Florida, Caribbean, Africa, Asia, Europe, India, or Pacific Ocean) please review the ADPH Chikungunya Recommendations, including reporting, patient education, specimen collection, shipping, and resources.
- ADPH will not test for MERS-CoV, unless a healthcare provider has determined the patient meet the MERS-CoV Case Definitions. If a patient meets the MERS-CoV case definition, the healthcare provider must call and report the possible case to Epidemiology Division at 1-800-338-8374. EPI will need at a minimum the CDC's MERS-CoV Short Investigation Form information.
- Review Alabama Emergency Response Technology (ALERT), and Center for Disease Control and Prevention (CDC) Health Alert Network (HAN) messages and Influenza Key Points.
- CDC's Clinician Outreach Communication Activity (COCA) Conference Call with free CE
- Review Alabama Morbidity Report
- The Epidemiology Division has launched a new awareness campaign, DETECT, TEST and REPORT Notifiable Diseases to determine Alabama's true disease burden.
- ADPH Notifiable Disease Rules Updated - See also: Summary of Changes and Alabama Notifiable Diseases/Conditions (Effective June 30, 2011)